Skip to main content

Advertisement

Table 3 Medication Use

From: Patient characteristics, comorbidities, and medication use for children with ADHD with and without a co-occurring reading disorder: A retrospective cohort study

ADHD Medication ADHD ADHD + RD P Value
  N % N %  
Long-Acting Stimulants      
Adderall XR 30901 31.6 61 23.0 0.003
Concerta 30976 31.7 86 32.5 0.794
Daytrana 2749 2.8 11 4.2 0.189
Focalin XR 8002 8.2 30 11.3 0.064
Metadate CD 5426 5.6 19 7.2 0.251
Metadate ER 193 0.2 0 0.0 1.000
Methylin ER 1083 1.1 5 1.9 0.227
Methylphenidate HCL ER 0 0.0 0 0.0 N/A
Methylphenidate HCL SR 0 0.0 0 0.0 N/A
Ritalin LA 4574 4.7 15 5.7 0.451
Ritalin SR 39 0.0 0 0.0 1.000
Vyvanse 262 0.3 0 0.0 1.000
Total Long-Acting 69623 71.3 181 68.3 0.288
Short-Acting Stimulants      
Adderall 381 0.4 1 0.4 1.000
Amphetamine Salt Combo 9289 9.5 13 4.9 0.011
Amphetamine/Dextroamph 0 0.0 0 0.0 N/A
Cylert 0 0.0 0 0.0 N/A
Desoxyn 11 0.0 0 0.0 1.000
Dexedrine 27 0.0 0 0.0 1.000
Dexmethylphenidate HCL 109 0.1 1 0.4 0.258
Dextroamphetamine Sulfate 1231 1.3 1 0.4 0.272
Dextrostat 48 0.0 1 0.4 0.124
Dexampex 0 0.0 0 0.0 N/A
Focalin 3098 3.2 11 4.2 0.363
Methamphetamine HCL 0 0.0 0 0.0 N/A
Methylin 4986 5.1 13 4.9 0.884
Methylphenidate HCL 6701 6.9 19 7.2 0.841
Methylphenidate Hcl SA 0 0.0 0 0.0 N/A
Pemoline 10 0.0 0 0.0 1.000
Ritalin 397 0.4 2 0.8 0.293
Provigil 234 0.2 0 0.0 1.000
Total Short-Acting 22739 23.3 54 20.4 0.265
Total Stimulants 75354 77.1 190 71.7 0.036
Non-Stimulants      
Atomoxetine 13732 14.1 34 12.8 0.567
Bupropion 3486 3.6 10 3.8 0.857
Alpha 2 Agonists 11296 11.6 32 12.1 0.794
Total Non-Stimulants 25506 26.1 65 24.5 0.559
Medications used to treat Other Mental Health Conditions ADHD ADHD + RD P Value
  N % N %  
Anti-depressants      
MAOI's 0 0.0 0 0.0 N/A
Tricyclics 1734 1.8 3 1.1 0.638
SSRI's 9508 9.7 26 9.8 0.965
SNRI's 772 0.8 1 0.4 0.729
Other 5105 5.2 18 6.8 0.252
Total Antidepressants 14966 15.3 43 16.2 0.682
Antimanic (bipolar) agents 7208 7.4 21 7.9 0.734
Antipsychotics      
Typical 444 0.5 0 0.0 0.638
Atypical 15593 16.0 52 19.6 0.104
Total Antipsychotics 15703 16.1 52 19.6 0.116
Anxiolytics      
Benzodiazepines 1807 1.8 3 1.1 0.643
Others 2388 2.4 5 1.9 0.557
Total Anxiolytics 3982 4.1 8 3.0 0.385
  1. All comorbidties examined from index date through end of post-period.
  2. Based upon univariate analyses with chi-square tests for variables with counts of at least 5 and Fischer's exact test if any cell had less than 5 observations.